SCHEMBL24813343

SCHEMBL24813343

c1cncc(-c2ccc(-c3cccc(-c4ccc(-c5ccc6c(-c7ccc8ccccc8c7)c7ccccc7c(-c7ccc8ccccc8c7)c6c5)cc4)n3)cc2)c1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 10/20 0.61
CYP11B1 P15538 10/20 0.61
CYP19A1 P11511 8/20 0.61
CYP17A1 P05093 4/20 0.61
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
HSD17B1 P14061 1/20 0.44
CYP2B6 P20813 1/20 0.44
CYP2C19 P33261 1/20 0.44
HSD17B2 P37059 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
DHODH Q02127 1/20 0.44
SIRT2 Q8IXJ6 1/20 0.42
ERN1 O75460 1/20 0.42
CYP2A6 P11509 2/20 0.41
PGR P06401 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24812257 0.98 CYP11B2 (0.57) CYP11B2CYP11B1CYP19A1CYP17A1CYP1A2
SCHEMBL13658726 0.93 CYP11B1 (0.56) CYP11B2CYP11B1CYP19A1CYP17A1CYP1A2
SCHEMBL15977665 0.92 CYP11B2 (0.71) CYP11B2CYP11B1CYP19A1CYP17A1CYP1A2
SCHEMBL26467391 0.91 CYP11B2 (0.69) CYP11B2CYP11B1CYP19A1CYP17A1CYP1A2
SCHEMBL10030055 0.91 CYP11B2 (0.69) CYP11B2CYP11B1CYP19A1CYP17A1CYP1A2
SCHEMBL10300977 0.91 CYP11B2 (0.73) CYP11B2CYP11B1CYP19A1CYP17A1CYP1A2
SCHEMBL15977618 0.90 CYP11B2 (0.68) CYP11B2CYP11B1CYP19A1CYP17A1CYP1A2
SCHEMBL13015625 0.90 CYP11B1 (0.59) CYP11B2CYP11B1CYP19A1CYP17A1CYP1A2
SCHEMBL10030070 0.90 CYP11B2 (0.71) CYP11B2CYP11B1CYP19A1CYP17A1CYP1A2
SCHEMBL24810526 0.89 CYP11B2 (0.59) CYP11B2CYP11B1CYP19A1CYP17A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS PIEZO1, TMEM109, SLC39A14 CYP11B2 1585/4885CYP11B1 1241/4885CYP19A1 936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.